{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T19:39:21Z","timestamp":1793907561317,"version":"4.8.0"},"reference-count":49,"publisher":"American Medical Association (AMA)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA"],"published-print":{"date-parts":[[2021,8,24]]},"DOI":"10.1001\/jama.2021.12531","type":"journal-article","created":{"date-parts":[[2021,8,24]],"date-time":"2021-08-24T11:18:40Z","timestamp":1629803920000},"page":"736","source":"Crossref","is-referenced-by-count":475,"title":["Screening for Prediabetes and Type 2 Diabetes"],"prefix":"10.1001","volume":"326","author":[{"name":"US Preventive Services Task Force","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karina W.","family":"Davidson","sequence":"additional","affiliation":[{"name":"Feinstein Institutes for Medical Research at Northwell Health, Manhasset, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Barry","sequence":"additional","affiliation":[{"name":"Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carol M.","family":"Mangione","sequence":"additional","affiliation":[{"name":"University of California, Los Angeles"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Cabana","sequence":"additional","affiliation":[{"name":"Albert Einstein College of Medicine, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron B.","family":"Caughey","sequence":"additional","affiliation":[{"name":"Oregon Health & Science University, Portland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esa M.","family":"Davis","sequence":"additional","affiliation":[{"name":"University of Pittsburgh, Pittsburgh, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katrina E.","family":"Donahue","sequence":"additional","affiliation":[{"name":"University of North Carolina at Chapel Hill"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chyke A.","family":"Doubeni","sequence":"additional","affiliation":[{"name":"Mayo Clinic, Rochester, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex H.","family":"Krist","sequence":"additional","affiliation":[{"name":"Fairfax Family Practice Residency, Fairfax, Virginia"},{"name":"Virginia Commonwealth University, Richmond"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martha","family":"Kubik","sequence":"additional","affiliation":[{"name":"George Mason University, Fairfax, Virginia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Li","sequence":"additional","affiliation":[{"name":"University of Virginia, Charlottesville"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gbenga","family":"Ogedegbe","sequence":"additional","affiliation":[{"name":"New York University, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas K.","family":"Owens","sequence":"additional","affiliation":[{"name":"Stanford University, Stanford, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lori","family":"Pbert","sequence":"additional","affiliation":[{"name":"University of Massachusetts Medical School, Worcester"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Silverstein","sequence":"additional","affiliation":[{"name":"Boston University, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Stevermer","sequence":"additional","affiliation":[{"name":"University of Missouri, Columbia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chien-Wen","family":"Tseng","sequence":"additional","affiliation":[{"name":"University of Hawaii, Honolulu"},{"name":"Pacific Health Research and Education Institute, Honolulu, Hawaii"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John B.","family":"Wong","sequence":"additional","affiliation":[{"name":"Tufts University School of Medicine, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"key":"jus210018r3","doi-asserted-by":"crossref","first-page":"17","DOI":"10.7812\/TPP\/17-050","article-title":"A simple model for predicting two-year risk of diabetes development in individuals with prediabetes.","volume":"22","author":"Glauber","year":"2018","journal-title":"Perm J"},{"issue":"13","key":"jus210018r4","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.4239\/wjd.v6.i13.1246","article-title":"Diabetes and cardiovascular disease: epidemiology, biological mechanisms, treatment recommendations and future research.","volume":"6","author":"Leon","year":"2015","journal-title":"World J Diabetes"},{"issue":"6","key":"jus210018r5","doi-asserted-by":"publisher","first-page":"2231","DOI":"10.1210\/jc.2015-1966","article-title":"High prevalence of nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus and normal plasma aminotransferase levels.","volume":"100","author":"Portillo-Sanchez","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"jus210018r6","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1016\/j.jhep.2019.06.021","article-title":"The global epidemiology of NAFLD and NASH in patients with type 2 diabetes: a systematic review and meta-analysis.","volume":"71","author":"Younossi","year":"2019","journal-title":"J Hepatol"},{"issue":"2","key":"jus210018r8","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1038\/nrendo.2017.151","article-title":"Global aetiology and epidemiology of type 2 diabetes mellitus and its complications.","volume":"14","author":"Zheng","year":"2018","journal-title":"Nat Rev Endocrinol"},{"issue":"10","key":"jus210018r9","doi-asserted-by":"publisher","first-page":"3848","DOI":"10.1210\/jc.2017-01354","article-title":"Development and risk factors of type 2 diabetes in a nationwide population of women with polycystic ovary syndrome.","volume":"102","author":"Rubin","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"jus210018r10","doi-asserted-by":"publisher","first-page":"258","DOI":"10.2337\/dci20-0053","article-title":"Social determinants of health and diabetes: a scientific review.","volume":"44","author":"Hill-Briggs","year":"2020","journal-title":"Diabetes Care"},{"issue":"2","key":"jus210018r12","doi-asserted-by":"publisher","first-page":"353","DOI":"10.2337\/dc10-0746","article-title":"Trends in the prevalence of type 2 diabetes in Asians versus Whites: results from the United States National Health Interview Survey, 1997-2008.","volume":"34","author":"Lee","year":"2011","journal-title":"Diabetes Care"},{"issue":"5","key":"jus210018r13","doi-asserted-by":"publisher","first-page":"814","DOI":"10.2337\/dc14-2071","article-title":"Optimum BMI cut points to screen Asian Americans for type 2 diabetes.","volume":"38","author":"Araneta","year":"2015","journal-title":"Diabetes Care"},{"key":"jus210018r14","doi-asserted-by":"publisher","first-page":"S14","DOI":"10.2337\/dc20-S002","article-title":"Classification and diagnosis of diabetes: standards of medical care in diabetes\u20142020.","volume":"43","author":"American Diabetes Association","year":"2020","journal-title":"Diabetes Care"},{"issue":"9","key":"jus210018r15","doi-asserted-by":"publisher","first-page":"2016","DOI":"10.2337\/dc10-0588","article-title":"A1C to detect diabetes in healthy adults: when should we recheck?","volume":"33","author":"Takahashi","year":"2010","journal-title":"Diabetes Care"},{"issue":"9723","key":"jus210018r16","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1016\/S0140-6736(09)62162-0","article-title":"Age at initiation and frequency of screening to detect type 2 diabetes: a cost-effectiveness analysis.","volume":"375","author":"Kahn","year":"2010","journal-title":"Lancet"},{"issue":"8","key":"jus210018r17","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.2337\/dc14-2459","article-title":"Early detection and treatment of type 2 diabetes reduce cardiovascular morbidity and mortality: a simulation of the results of the Anglo-Danish-Dutch Study of Intensive Treatment in People With Screen-Detected Diabetes in Primary Care (ADDITION-Europe).","volume":"38","author":"Herman","year":"2015","journal-title":"Diabetes Care"},{"issue":"6","key":"jus210018r18","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1056\/NEJMoa012512","article-title":"Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin.","volume":"346","author":"Knowler","year":"2002","journal-title":"N Engl J Med"},{"issue":"4","key":"jus210018r19","doi-asserted-by":"publisher","first-page":"601","DOI":"10.2337\/dc18-1970","article-title":"Long-term effects of metformin on diabetes prevention: identification of subgroups that benefited most in the Diabetes Prevention Program and Diabetes Prevention Program Outcomes Study.","volume":"42","author":"Diabetes Prevention Program Research Group","year":"2019","journal-title":"Diabetes Care"},{"issue":"11","key":"jus210018r20","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1001\/jama.2018.13022","article-title":"Behavioral weight loss interventions to prevent obesity-related morbidity and mortality in adults: US Preventive Services Task Force recommendation statement.","volume":"320","author":"Curry","year":"2018","journal-title":"JAMA"},{"issue":"11","key":"jus210018r21","doi-asserted-by":"publisher","first-page":"861","DOI":"10.7326\/M15-2345","article-title":"Screening for abnormal blood glucose and type 2 diabetes mellitus: U.S. Preventive Services Task Force recommendation statement.","volume":"163","author":"Siu","year":"2015","journal-title":"Ann Intern Med"},{"issue":"4","key":"jus210018r22","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/j.amepre.2014.05.012","article-title":"Reconsidering the age thresholds for type II diabetes screening in the U.S.","volume":"47","author":"Chung","year":"2014","journal-title":"Am J Prev Med"},{"key":"jus210018r23","article-title":"Screening for prediabetes and type 2 diabetes: updated evidence report and systematic review for the US Preventive Services Task Force.","author":"Jonas","year":"2021","journal-title":"JAMA"},{"key":"jus210018r24","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1186\/1471-2458-9-136","article-title":"The ADDITION-Cambridge trial protocol: a cluster-randomised controlled trial of screening for type 2 diabetes and intensive treatment for screen-detected patients.","volume":"9","author":"Echouffo-Tcheugui","year":"2009","journal-title":"BMC Public Health"},{"issue":"9855","key":"jus210018r25","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.1016\/S0140-6736(12)61422-6","article-title":"Screening for type 2 diabetes and population mortality over 10 years (ADDITION-Cambridge): a cluster-randomised controlled trial.","volume":"380","author":"Simmons","year":"2012","journal-title":"Lancet"},{"issue":"2","key":"jus210018r26","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1370\/afm.1737","article-title":"Long-term effect of population screening for diabetes on cardiovascular morbidity, self-rated health, and health behavior.","volume":"13","author":"Echouffo-Tcheugui","year":"2015","journal-title":"Ann Fam Med"},{"issue":"2","key":"jus210018r27","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1007\/s00125-010-1949-8","article-title":"Effect of population screening for type 2 diabetes on mortality: long-term follow-up of the Ely cohort.","volume":"54","author":"Simmons","year":"2011","journal-title":"Diabetologia"},{"issue":"6","key":"jus210018r28","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.1007\/s00125-011-2441-9","article-title":"How much does screening bring forward the diagnosis of type 2 diabetes and reduce complications? twelve year follow-up of the Ely cohort.","volume":"55","author":"Rahman","year":"2012","journal-title":"Diabetologia"},{"issue":"7","key":"jus210018r29","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1111\/dme.2012.29.issue-7","article-title":"Effect of screening for type 2 diabetes on population-level self-rated health outcomes and measures of cardiovascular risk: 13-year follow-up of the Ely cohort.","volume":"29","author":"Rahman","year":"2012","journal-title":"Diabet Med"},{"issue":"9786","key":"jus210018r30","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/S0140-6736(11)60698-3","article-title":"Effect of early intensive multifactorial therapy on 5-year cardiovascular outcomes in individuals with type 2 diabetes detected by screening (ADDITION-Europe): a cluster-randomised trial.","volume":"378","author":"Griffin","year":"2011","journal-title":"Lancet"},{"issue":"11","key":"jus210018r31","doi-asserted-by":"publisher","first-page":"e409","DOI":"10.1111\/dme.2012.29.issue-11","article-title":"Does early intensive multifactorial treatment reduce total cardiovascular burden in individuals with screen-detected diabetes? findings from the ADDITION-Europe cluster-randomized trial.","volume":"29","author":"Simmons","year":"2012","journal-title":"Diabet Med"},{"issue":"64","key":"jus210018r32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3310\/hta20640","article-title":"A randomised trial of the effect and cost-effectiveness of early intensive multifactorial therapy on 5-year cardiovascular outcomes in individuals with screen-detected type 2 diabetes: the Anglo-Danish-Dutch Study of Intensive Treatment in People With Screen-Detected Diabetes in Primary Care (ADDITION-Europe) study.","volume":"20","author":"Simmons","year":"2016","journal-title":"Health Technol Assess"},{"issue":"12","key":"jus210018r33","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1016\/S2213-8587(19)30349-3","article-title":"Long-term effects of intensive multifactorial therapy in individuals with screen-detected type 2 diabetes in primary care: 10-year follow-up of the ADDITION-Europe cluster-randomised trial.","volume":"7","author":"Griffin","year":"2019","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"6","key":"jus210018r34","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1016\/S2213-8587(14)70057-9","article-title":"Cardiovascular mortality, all-cause mortality, and diabetes incidence after lifestyle intervention for people with impaired glucose tolerance in the Da Qing Diabetes Prevention Study: a 23-year follow-up study.","volume":"2","author":"Li","year":"2014","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"6","key":"jus210018r35","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1016\/S2213-8587(19)30093-2","article-title":"Morbidity and mortality after lifestyle intervention for people with impaired glucose tolerance: 30-year results of the Da Qing Diabetes Prevention Outcome Study.","volume":"7","author":"Gong","year":"2019","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"9131","key":"jus210018r36","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1016\/S0140-6736(98)07019-6","article-title":"Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33).","volume":"352","author":"UK Prospective Diabetes Study (UKPDS) Group","year":"1998","journal-title":"Lancet"},{"issue":"15","key":"jus210018r37","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1056\/NEJMoa0806470","article-title":"10-Year follow-up of intensive glucose control in type 2 diabetes.","volume":"359","author":"Holman","year":"2008","journal-title":"N Engl J Med"},{"issue":"9131","key":"jus210018r38","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1016\/S0140-6736(98)07037-8","article-title":"Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34).","volume":"352","author":"UK Prospective Diabetes Study (UKPDS) Group","year":"1998","journal-title":"Lancet"},{"issue":"7642","key":"jus210018r39","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1136\/bmj.39474.922025.BE","article-title":"Effectiveness of the Diabetes Education and Self Management for Ongoing and Newly Diagnosed (DESMOND) programme for people with newly diagnosed type 2 diabetes: cluster randomised controlled trial.","volume":"336","author":"Davies","year":"2008","journal-title":"BMJ"},{"key":"jus210018r40","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.e2333","article-title":"Effectiveness of a diabetes education and self management programme (DESMOND) for people with newly diagnosed type 2 diabetes mellitus: three year follow-up of a cluster randomised controlled trial in primary care.","volume":"344","author":"Khunti","year":"2012","journal-title":"BMJ"},{"issue":"4","key":"jus210018r41","doi-asserted-by":"publisher","first-page":"978","DOI":"10.2337\/dc12-0227","article-title":"Primary prevention of macroangiopathy in patients with short-duration type 2 diabetes by intensified multifactorial intervention: seven-year follow-up of diabetes complications in Chinese.","volume":"36","author":"Yang","year":"2013","journal-title":"Diabetes Care"},{"issue":"6","key":"jus210018r42","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1016\/j.amepre.2017.01.008","article-title":"PREVENT-DM comparative effectiveness trial of lifestyle intervention and metformin.","volume":"52","author":"O\u2019Brien","year":"2017","journal-title":"Am J Prev Med"},{"issue":"4","key":"jus210018r43","doi-asserted-by":"crossref","first-page":"888","DOI":"10.2337\/diacare.28.4.888","article-title":"Impact of intensive lifestyle and metformin therapy on cardiovascular disease risk factors in the Diabetes Prevention Program.","volume":"28","author":"Ratner","year":"2005","journal-title":"Diabetes Care"},{"key":"jus210018r44","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1186\/1471-2458-8-350","article-title":"Screening for type 2 diabetes is feasible, acceptable, but associated with increased short-term anxiety: a randomised controlled trial in British general practice.","volume":"8","author":"Park","year":"2008","journal-title":"BMC Public Health"},{"issue":"7618","key":"jus210018r45","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1136\/bmj.39303.723449.55","article-title":"Psychological impact of screening for type 2 diabetes: controlled trial and comparative study embedded in the ADDITION (Cambridge) randomised controlled trial.","volume":"335","author":"Eborall","year":"2007","journal-title":"BMJ"},{"issue":"pt 1","key":"jus210018r46","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1348\/135910710X495366","article-title":"Predictors of anxiety and depression among people attending diabetes screening: a prospective cohort study embedded in the ADDITION (Cambridge) randomized control trial.","volume":"16","author":"Paddison","year":"2011","journal-title":"Br J Health Psychol"},{"key":"jus210018r48","doi-asserted-by":"publisher","first-page":"S13","DOI":"10.2337\/dc18-S002","article-title":"Classification and diagnosis of diabetes: standards of medical care in diabetes\u20142018.","volume":"41","author":"American Diabetes Association","year":"2018","journal-title":"Diabetes Care"},{"key":"jus210018r49","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4158\/EP15672.GLSUPPL","article-title":"American Association of Clinical Endocrinologists and American College of Endocrinology clinical practice guidelines for developing a diabetes mellitus comprehensive care plan\u20142015.","volume":"21","author":"Handelsman","year":"2015","journal-title":"Endocr Pract"},{"key":"jus210018r2","volume-title":"Screening for Abnormal Blood Glucose and Type 2 Diabetes Mellitus: An Evidence Review for the U.S. Preventive Services Task Force. Evidence Synthesis No. 207","author":"Jonas","year":"2021"},{"key":"jus210018r1","unstructured":"Centers for Disease Control and Prevention. National Diabetes Statistics Report, 2020. Accessed June 29, 2021. https:\/\/www.cdc.gov\/diabetes\/pdfs\/data\/statistics\/national-diabetes-statistics-report.pdf"},{"key":"jus210018r7","unstructured":"Procedure Manual. US Preventive Services Task Force. Published May 2021. Accessed June 29, 2021. https:\/\/uspreventiveservicestaskforce.org\/uspstf\/about-uspstf\/methods-and-processes\/procedure-manual"},{"key":"jus210018r11","unstructured":"Diabetes and Asian Americans. Centers for Disease Control and Prevention. Accessed June 29, 2021. https:\/\/www.cdc.gov\/diabetes\/library\/spotlights\/diabetes-asian-americans.html"},{"key":"jus210018r47","unstructured":"Metformin [package insert]. Bristol Myers Squibb. Accessed June 29, 2021. https:\/\/packageinserts.bms.com\/pi\/pi_glucophage.pdf"}],"container-title":["JAMA"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jama\/articlepdf\/2783414\/jama_davidson_2021_us_210018_1634939301.84191.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,7]],"date-time":"2023-01-07T18:46:07Z","timestamp":1673117167000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jama\/fullarticle\/2783414"}},"subtitle":["US Preventive Services Task Force Recommendation Statement"],"short-title":[],"issued":{"date-parts":[[2021,8,24]]},"references-count":49,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2021,8,24]]}},"URL":"https:\/\/doi.org\/10.1001\/jama.2021.12531","relation":{},"ISSN":["0098-7484"],"issn-type":[{"value":"0098-7484","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8,24]]}}}